pentoxifylline has been researched along with Leucocythaemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bravo-Cuellar, A | 2 |
| Hernández-Flores, G | 2 |
| Lerma-Díaz, JM | 2 |
| Domínguez-Rodríguez, JR | 2 |
| Jave-Suárez, LF | 2 |
| De Célis-Carrillo, R | 1 |
| Aguilar-Lemarroy, A | 2 |
| Gómez-Lomeli, P | 1 |
| Ortiz-Lazareno, PC | 2 |
| Gómez-Contreras, P | 1 |
| Cervantes-Munguía, R | 1 |
| Scott-Algara, D | 1 |
| Biddle, W | 1 |
| Ambrus, CM | 1 |
| Gastpar, H | 1 |
| Ambrus, JL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Enhancing Effect on Tumour Apoptosis With the Combined Use of Pentoxifylline Plus Chemotherapeutical Agents in Pediatrics and AYA Patients With Hodgkin´s Lymphoma[NCT05490953] | Phase 4 | 30 participants (Anticipated) | Interventional | 2022-07-11 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for pentoxifylline and Leucocythaemia
| Article | Year |
|---|---|
Pentoxifylline and the proteasome inhibitor MG132 induce apoptosis in human leukemia U937 cells through a decrease in the expression of Bcl-2 and Bcl-XL and phosphorylation of p65.
Topics: Apoptosis; bcl-X Protein; Carrier Proteins; Gene Expression Regulation, Leukemic; Humans; Intracellu | 2013 |
In vivo and in vitro sensitization of leukemic cells to adriamycin-induced apoptosis by pentoxifylline. Involvement of caspase cascades and IkappaBalpha phosphorylation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspases; Doxorubicin; Humans; I-kappa | 2006 |
Antineoplastic effect of the xanthine derivative Trental.
Topics: B-Lymphocytes; Burkitt Lymphoma; Cell Line; Combined Modality Therapy; DNA; Humans; Interferon Type | 1984 |